Can drugs cause schizophrenia?
Schizophrenia, a severe psychotic disorder that disrupts an individual’s perception of reality, has long been a source of fascination within the medical community. However, the relationship between schizophrenia and substance abuse has often been overlooked, leaving many individuals and their loved ones with the complexities of this dual diagnosis. This article will look into this connection, exploring the potential impact of alcohol and drug use on the development and progression of schizophrenia.
Understanding schizophrenia
Schizophrenia is a complex mental illness that shows up through a range of psychotic symptoms, including delusional beliefs, hallucinations and disorganised thoughts. This disorder can have a profound impact on an individual’s ability to function in various aspects of life, from work and relationships to social interactions and personal care. The onset of schizophrenia typically occurs during the teenage years or early adulthood, a critical period of development, further underscoring the significance of this condition.
Schizophrenia and substance abuse
The relationship between schizophrenia and drug abuse is complex with a significant overlap in the prevalence of these two conditions. Studies have consistently shown that the rate of substance use among individuals with schizophrenia is significantly higher than in the general population, with alcohol, nicotine, cocaine, amphetamines and marijuana being the most commonly abused substances.
How substance abuse impacts schizophrenia
The co-occurrence of schizophrenia and substance abuse can have a profound impact on the severity and progression of both conditions. Substance abuse can intensify the symptoms of schizophrenia, leading to more frequent psychotic episodes, increased risk of hospitalisation, incarceration, and even suicide attempts. Conversely, the symptoms of schizophrenia, such as delusional beliefs, hallucinations, and disorganised thought patterns, can make it challenging for individuals to recognise and address their substance abuse issues.
Masking the symptoms
One of the key challenges in identifying and treating the dual diagnosis of schizophrenia and substance abuse is how the two conditions can mask each other’s symptoms. The effects of drug or alcohol abuse can obscure the underlying signs of schizophrenia, making it difficult for healthcare providers to accurately diagnose and address the root causes of the individual’s struggles. Similarly, the cognitive and behavioural disturbances associated with schizophrenia can make it challenging to recognise and address the individual’s substance abuse issues.
Causes of schizophrenia
The origins of schizophrenia and its relationship with substance abuse are many, involving a complex interplay of various factors. Researchers have identified several potential contributors to the development of this disorder, including:
Neurochemical imbalances
Imbalances in certain neurotransmitters, such as dopamine and glutamate, have been strongly linked to the thought patterns and behaviours associated with schizophrenia. These neurochemical irregularities may play a significant role in the development and progression of the disorder.
Structural brain differences
Imaging studies have revealed structural differences in the brains of individuals with schizophrenia, particularly in the frontal lobe, which is responsible for cognitive functioning and decision-making.
Genetic predisposition
While a single gene does not cause schizophrenia, research suggests that there is a genetic component to the disorder, with a higher risk of developing schizophrenia among close relatives and twins.
Environmental factors
Factors such as complications during pregnancy, exposure to toxins or viruses, and traumatic life experiences have been proposed as potential environmental contributors to the development of schizophrenia.
The role of substance abuse
While substance abuse does not directly cause schizophrenia, the chronic and excessive use of drugs or alcohol can exacerbate the symptoms of the disorder and increase the frequency of psychosis. Certain substances, such as cannabis, LSD, and stimulants, have been specifically linked to the onset or worsening of schizophrenic symptoms.
Understanding the nature of the underlying causes of schizophrenia and substance abuse is crucial in developing comprehensive and effective treatment approaches.
Signs and symptoms of schizophrenia
Recognising the signs and symptoms of schizophrenia is essential for early intervention and effective treatment. The symptoms of this disorder can be broadly categorised into four main areas:
- Sensory symptoms: Visual and auditory hallucinations, such as seeing things that are not present or hearing voices others cannot hear
- Cognitive symptoms: Include difficulty understanding or using language, disorganised thinking, and false beliefs about achievements or persecution
- Behavioural symptoms: Social withdrawal, neglect of personal hygiene, fear of interacting with others, and unpredictable or erratic behaviour
- Emotional symptoms: Flat facial expressions, inappropriate emotional responses, lack of empathy, and unexplained mood changes
These symptoms can manifest in various ways, and their severity can fluctuate over time. It is important to note that the early signs of schizophrenia, such as changes in speech, loss of interest in activities, and social withdrawal, may not be immediately recognised as indicators of the disorder, particularly in individuals struggling with substance abuse.
Complexities of dual diagnosis treatment
Treating individuals with a dual diagnosis of schizophrenia and substance abuse requires a comprehensive approach that addresses both the mental health condition and addiction-related components of the individual’s condition.
Role of medication in schizophrenia treatment
Antipsychotic medications, both older “typical” and newer “atypical” formulations, play a crucial role in managing the symptoms of schizophrenia. These medications can help reduce the severity of hallucinations, delusional beliefs, and other psychotic experiences, allowing individuals to engage more effectively in their recovery process.
Psychosocial interventions
In addition to medication, a range of psychosocial interventions are essential in the treatment of schizophrenia and substance abuse. These may include individual therapy, group therapy, family systems therapy, cognitive-behavioral therapy (CBT), and trauma-focused therapies. These approaches aim to address the psychological and behavioural aspects of both conditions, helping individuals develop coping strategies and build a supportive network.
Ongoing support
The recovery process for individuals with a dual diagnosis of schizophrenia and substance abuse is often a lifelong journey. Aftercare and ongoing support, such as regular check-ins, access to mental health and addiction services, and participation in support groups, are crucial in maintaining long-term stability and preventing relapse.
Conclusion
The relationship between schizophrenia and substance abuse is a complex one, with profound implications for individuals and their loved ones. By understanding the nuances of this dual diagnosis, healthcare providers, policymakers, and the general public can work together to develop more effective treatment approaches, reduce the stigma surrounding these conditions, and provide the necessary support and resources to those in need.
Sources
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
Trusted and certified to keep your data safe.
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111